Biovie Inc (BIVI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.12M
Last updated: Nov 17, 2026 at 11:02 AM ET
Biovie Inc (BIVI) Stock Forecast
Analysts expect Biovie (BIVI) to earn -$0.63 per share in the fiscal year ending Jun 30, 2027. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$0.57.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Jun 30, 2027
- -$0.63
- EPS consensus
- Fiscal year ending Jun 30, 2028
- -$0.57
- EPS consensus
- Next report
- Feb 4, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Jun 30, 2027 | -$0.63 | -$0.63 to -$0.63 | 1 |
| Jun 30, 2028 | -$0.57 | -$0.57 to -$0.57 | 1 |
Estimate Revisions
No EPS estimate for the 2 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 0 | 0 |
| Fiscal year ending Jun 30, 2028 | 0 | 0 |
Frequently Asked Questions About BIVI
What is the BIVI stock forecast?
Consensus analyst estimates put Biovie's EPS at -$0.63 for the fiscal year ending Jun 30, 2027.
What EPS do analysts expect from BIVI next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$0.63, with estimates from -$0.63 to -$0.63 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$0.57, with estimates from -$0.57 to -$0.57 from 1 analyst.
How many analysts cover BIVI?
1 analyst estimates EPS for Biovie for the fiscal year ending Jun 30, 2027.
BIVI pages: Overview, Earnings, Forecast, Financials, Competitors